The latter half of the twentieth century has witnessed rapid advances in cardiovascular epidemiology and medicine. Concurrently, secular trends in lifestyle practices and general improvements in standards of living have resulted in several alarming trends for cardiovascular disease prevention and health promotion. The adoption of unhealthy dietary patterns, growing socio-economic and racial disparities in chronic disease prevalence, low levels of physical activity, and other as yet unidentified genetic and environmental determinants have led to burgeoning rates of both pediatric and adult obesity and diabetes mellitus. Women appear to be at particular risk as the gender advantage for coronary heart disease (CHD) is counterbalanced by an increased incidence of obesity and diabetes. In order to further examine these complex associations, we review the available epidemiological data regarding the impact of obesity and diabetes on cardiovascular health in women.
Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 1998. WHO/NUT/NCD/98.1.
2.
CaballeroB.Introduction. Symposium. Obesity in developing countries: Biological and ecological factors. J Nutr2001; 131:866S–870S.
3.
RevickiDAIsraelRG.Relationship between body mass indices and measures of body adiposity. Am J Public Health1986; 76:992–994.
4.
SpiegelmanDIsraelRGBouchardCWillettWC.Absolute fat mass, percent body fat, and body-fat distribution: Which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr1992; 55:1033–1044.
5.
TornaghiGRaiteriRPozzatoCRispoliABramaniMCipolatMAnthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int J Obes Relat Metab Disord1994; 18:771–775.
6.
BertinEMarcusCRuizJCEschardJPLeuteneggerM.Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans. Int J Obes Relat Metab Disord2000; 24:263–270.
7.
RossRLegerLMorrisDde GuiseJGuardoR.Quantification of adipose tissue by MRI: Relationship with anthropometric variables. J Appl Physiol1992; 72:787–795.
8.
VagueJ.The degree of masculin differentiation of obesities: A factor determining predispositionto diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr1956; 4:20–34.
FilipovskyJDucimetierePDarneBRichardJL.Abdominal body mass distribution and elevated blood pressure are associated with increased risk of death from cardiovascular diseases and cancer in middle-aged men. The results of a 15- to 20-year follow-up in the Paris prospective study I. Int J Obes Relat Metab Disord1993; 17:197–203.
11.
PrineasRJFolsomARKayeSA.Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol1993; 3:35–41.
12.
NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: National Heart, Lung and, Blood Institute; 1998.
13.
Department of Agriculture DoHaHS. Nutrition and your health: Dietary guidelines for Americans, 3rd Edition. Washington, DC: Government Printing Office; 1990.
14.
HigginsMKannelWGarrisonRPinskyJStokesJ, 3rd. Hazards of obesity–the Framingham experience. Acta Med Scand Suppl1988; 723:23–36.
15.
HanTSvan LeerEMSeidellJCLeanME.Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ1995; 311:1401–1405.
16.
DyerARElliottP.The INTERSALTstudy: Relations of body mass index to blood pressure. INTERSALTCo-operative Research Group. J Hum Hypertens1989; 3:299–308.
17.
MertensILVan GaalLF.Overweight, obesity, and blood pressure: The effects of modest weight reduction. Obes Res2000; 8:270–278.
18.
BrunzellJDHokansonJE.Dyslipidemia of central obesity and insulin resistance. Diabetes Care1999; 22(Suppl 3):C10–C13.
19.
BermanDMNicklasBJRogusEMDennisKEGoldbergAP.Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women. Metabolism1998; 47:467–473.
20.
BodenG.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes1997; 46:3–10.
21.
AbateNGargAPeshockRMStray-GundersenJGrundySM.Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest1995; 96:88–98.
22.
CareyDGJenkinsABCampbellLVFreundJChisholmDJ.Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes1996; 45:633–638.
23.
GoodpasterBHThaeteFLSimoneauJAKelleyDE.Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes1997; 46:1579–1585.
24.
KelleyDEThaeteFLTroostFHuweTGoodpasterBH.Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab2000; 278:E941–E948.
25.
Al SuwaidiJHiganoSTHolmesDRJrLennonRLermanA.Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol2001; 37:1523–1528.
26.
MansonJEWillettWCStampferMJColditzGAHunterDJHankinsonSEBody weight and mortality among women. N Engl J Med1995; 333:677–685.
27.
WillettWCMansonJEStampferMJColditzGARosnerBSpeizerFEWeight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. JAMA1995; 273:461–465.
28.
RissanenAKnektPHeliovaaraMAromaaAReunanenAMaatelaJ.Weight and mortality in Finnish women. J Clin Epidemiol1991; 44:787–795.
29.
StevensJCaiJPamukERWilliamsonDFThunMJWoodJL.The effect of age on the association between body-mass index and mortality. N Engl J Med1998; 338:1–7.
30.
BengtssonCBjorkelundCLapidusLLissnerL.Associations of serum lipid concentrations and obesity with mortality in women: 20-year follow-up of participants in prospective population study in Gothenburg, Sweden. BMJ1993; 307:1385–1388.
31.
RexrodeKMCareyVJHennekensCHWaltersEEColditzGAStampferMJAbdominal adiposity and coronary heart disease in women. JAMA1998; 280:1843–1848.
32.
KingHAubertREHermanWH.Global burden of diabetes, 1995–2025: Prevalence, numerical estimates, and projections. Diabetes Care1998; 21:1414–1431.
33.
KannelWBMcGeeDL.Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care1979; 2:120–126.
34.
HeydenSHeissGBartelAGHamesCG.Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis1980; 33:265–273.
35.
Barrett-ConnorEWingardDL.Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol1983; 118:489–496.
36.
ButlerWJOstranderLDJrCarmanWJLamphiearDE.Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol1985; 121:541–547.
37.
PanWHCedresLBLiuKDyerASchoenbergerJAShekelleRBRelationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol1986; 123:504–516.
38.
KleinmanJCDonahueRPHarrisMIFinucaneFFMadansJHBrockDB.Mortality among diabetics in a national sample. Am J Epidemiol1988; 128:389–401.
39.
MansonJEColditzGAStampferMJWillettWCKrolewskiASRosnerBA prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med1991; 151:1141–1147.
40.
SeemanTMendes de LeonCBerkmanLOstfeldA.Risk factors for coronary heart disease among older men and women: A prospective study of community-dwelling elderly. Am J Epidemiol1993; 138:1037–1049.
41.
KuusistoJMykkanenLPyoralaKLaaksoM.NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes1994; 43:960–967.
42.
VilbergssonSSigurdssonGSigvaldasonHSigfussonN.Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: The independent effect of diabetes. The Reykjavik Study 17-year follow-up. J Intern Med1998; 244:309–316.
43.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care1997; 20:1183–1197.
44.
Report of a WHO Consultation, Part 1Diagnosis and Classification of Diabetes Mellitus, Geneva. Geneva: World Health Organization; 1999. WHO/NCD/NCS/99.2.
45.
StolkRPOrchardTJGrobbeeDE.Why use the oral glucose tolerance test? Diabetes Care1995; 18:1045–1049.
46.
Fagot-CampagnaAPettittDJEngelgauMMBurrowsNRGeissLSValdezRType II diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr2000; 136:664–672.
47.
HarrisMI.Non-insulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev1990; 6:71–90.
48.
UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care1997; 20:1683–1687.
49.
AustinMAHokansonJEEdwardsKL.Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol1998; 81:7B–12B.
50.
ReavenGM.Banting lecture 1988. Role of insulin resistance in human disease. Diabetes1988; 37:1595–1607.
51.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001; 285:2486–2497.
52.
KannelWBMcGeeDL.Diabetes and cardiovascular disease. The Framingham study. JAMA1979; 241:2035–2038.
53.
SaitoIFolsomARBrancatiFLDuncanBBChamblessLEMcGovernPG.Non-traditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med2000; 133:81–91.
54.
KrolewskiASKosinskiEJWarramJHLelandOSBusickEJAsmalACMagnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol1987; 59:750–755.
55.
KannelWBD'AgostinoRBWilsonPWBelangerAJGagnonDR.Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J1990; 120:672–676.
56.
GuKCowieCCHarrisMI.Diabetes and decline in heart disease mortality in US adults. JAMA1999; 281:1291–1297.
57.
Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol2000; 35:1122–1129.
58.
KingSBKosinskiASGuytonRALemboNJWeintraubWS.Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol2000; 35:1116–1121.
59.
EckelRHKraussRM.American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation1998; 97:2099–2100.
60.
GrundySMBenjaminIJBurkeGLChaitAEckelRHHowardBVDiabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation1999; 100:1134–1146.
